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Introduction:
Oral squamous cell carcinoma (OSCC) accounts for approximately 3% of all cancers worldwide.
(1) OSCC comprises more than 90% of all oral cancers, (2, 3) and if diagnosed early, it has a five-year survival rate of about 85%. (4) Nowadays, even with various scientific advancements being explored and discovered every day, the worldwide prognosis of oral cancer has diminished rather than improved. This is a recognized public health care problem with a high mortality and morbidity rate. (5) A wide range of molecules is involved in oral carcinogenesis. Aberrant expression of several genes is linked with the hallmarks of OSCC including uncontrolled cell proliferation, defective apoptosis, poor differentiation, epithelial/mesenchymal transition, metastasis, and angiogenesis. (6) The potential of molecular biomarkers for the diagnosis, prognosis, or monitoring of the treatment outcome in OSCC has been vastly explored during the last decades. In the era of personalized medicine, immunohistochemical detection and/or mRNA expression profiling of molecular biomarkers are expected to significantly contribute to the development of new screening tests with a high sensitivity and specificity and tailor-made therapies for OSCC. (7) Saliva contains a large number of proteins and peptides, which are used as biomarkers for the detection of different oral and systemic diseases. Saliva is one of the most candid tools for the diagnosis of OSCC because of its direct contact with oral cancerous lesions. (8) Salivary biomarkers have been proven as cost-effective adjuncts in the diagnosis of oral and oropharyngeal carcinoma. (8) In their review on salivary genomics in oral cancer, Shah et al have insisted that saliva is a potential biomarker for OSCC as it contains locally expressed proteins including alpha-amylase, lactoferrins, lysozymes, proline-rich proteins, mucins, histatins, cystatins, and transferrin. (8) Markopoulos et al stated that the molecular diagnosis of OSCC can be done at three levels. (9) Alterations in the cellular DNA causes variations in mRNA transcripts and intra-cellular or extracellular protein levels. Salivary biomarkers can be genetic, protein, or metabolomic markers. (10) Considering the wide range of salivary biomarkers, this study aimed to review the related recent studies in this field to summarize and help in better understanding the clinical significance of salivary biomarkers in the diagnosis of OSCC.
Methods and Materials:
The literature over the past 13 years (2004-2017) were searched through Google Scholar, ScienceDirect, Medline and PubMed databases by using relevant keywords including OSCC, biomarkers, diagnosis, prognosis, and treatment outcome. Finally, 34 articles were reviewed in this study.
Results:
The findings of the reviewed studies indicated that the majority of salivary biomarkers including subcutaneous adipose tissue (SAT), interleukin-8 (IL-8), Cyfra 21-1, 8-hydroxy-2-deoxyguanosine, malondialdehyde, lactate dehydrogenase (LDH), Annexin A8, ErbB2, carcinoembryonic antigen (CEA), C-reactive protein (CRP), and salivary proteomic biomarkers might be used as indicators for the detection of oral cancer and premalignant oral disease (PMOD) and as a potential marker in the prognosis of OSCC. Table 1 demonstrates the summary of the reviewed studies. In patients with OSCC, increased salivary sodium and chloride might reflect their overall dehydration status due to alcohol consumption rather than a consequence of OSCC itself.
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Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. A total of 77 salivary samples from both groups were analyzed using MALDI-TOF MS technology.
Identifying 24-mer ZNF510 peptide as OSCC-related salivary biomarkers via proteomic approach proved useful in adjunct diagnosis for early detection rather than specific diagnostic marker for progression of OSCC patients.
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Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Tumor and salivary MMPs are robust diagnostic biomarkers of OSCC.
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Salivary proteomics for oral cancer biomarker discovery. RNA isolation was done from the saliva supernatant, followed by two-round linear amplification with T7 RNA polymerase.
The utility of salivary transcriptome diagnostics is successfully demonstrated in this study for oral cancer detection.
Discussion:
Salivary proteomics is developing through the identification of unique biomarkers for early detection approaches including metabolomics, proteomics, genomics, and bioinformatics. (17) The salivary biomarkers are used because saliva encompasses a wide range of compounds, (45) it is easily accessible, (46) and the sampling process is comfortable for patients. (47) The method is noninvasive and safe with low chances of pathogen transmission in comparison with blood samples. (48) Also, saliva is easy to store (49) and does not coagulate. The systematic analysis of salivary proteomic biomarkers and screening of saliva provides an efficient diagnostic tool to turn salivary diagnostics into clinical reality for oral cancer. Because of cellular and molecular heterogeneity of OSCC, several genes are involved in oral carcinogenesis; therefore, the use of several potential biomarkers renders a more precise diagnosis than the use of any marker alone. (17) In Addition, due to the characteristics of saliva, such as its proximity with the oral cavity and noninvasive sampling, the focus on OSCC has been changed to serum and saliva analysis as an alternative to tissue analysis. (17) Salivary biomarkers of OSCC can be used for cancer detection and monitoring non-cancerous activities. (17) The salivary biomarkers discussed in this study can be used for the detection of altered mRNA transcripts and changed intra-cellular or extra-cellular protein levels, and they can be genetic, protein, or metabolomic biomarkers, (45) The detection of these changes by the use of new technologies such as mass spectrometry, gel electrophoresis, chromatography, microarrays, high performance liquid chromatography (HPLC), polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA) is a developing field associated with point-of-care technologies, electrochemical detection, RNA sequencing, and liquid biopsy. (17) Furthermore, primary screening by the use of saliva could be an excellent choice considering the advancements in proteomics and genomics.
The extensive sighting of biomarkers and their authentication will change the field of diagnosis for oral cancers and non-cancerous activities. This review provides a comprehensive assessment of the developing diagnostic proteomic tools and biomarkers for the early detection and diagnosis of OSCC by the use of saliva.
Conclusion:
According to the reviewed studies, salivary biomarker analysis seems to be a major development in the diagnosis of OSCC, and it is a fastgrowing field in scientific research. The results show that salivary biomarkers can be a useful diagnostic and prognostic tool in OSCC.
